Загрузка...
A New Immunological Prognostic Model Based on Immunohistochemistry for Extranodal Natural Killer/T-Cell Lymphoma Patients After Non-Anthracycline-Based Chemotherapy
PURPOSE: Programmed death ligand 1 (PD-L1) has been proposed as an important prognostic factor in many types of cancer. However, the role of predicting the prognosis of PD-L1 in extranodal natural killer/T-cell lymphoma (ENKTL) was controversial. Combining other biomarkers might enhance its predicti...
Сохранить в:
| Опубликовано в: : | Cancer Manag Res |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7085340/ https://ncbi.nlm.nih.gov/pubmed/32231439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S244176 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|